Background Data on carcinogenicity of human papillomavirus (HPV) types in the anus are
needed to inform anal cancer prevention through vaccination and screening. This is …

High-risk human papillomaviruses (HPVs) cause essentially all cervical cancers, most anal
and oropharyngeal cancers, and some vaginal, vulvar, and penile cancers. Improved …

Anal cancer incidence and mortality have been increasing over the past decade. Although
the incidence in the general population remains low, it is much higher in certain subgroups …

Human papillomavirus (HPV), a member of the Papillomaviridae family, is a small (8kb),
nonenveloped, double‐stranded DNA virus. HPV has a predilection for infecting cutaneous …

This chapter provides an overview of anal cancer and contemporary approaches for anal
precancer detection, beginning with a discussion of the biology and natural history of anal …

Human papillomavirus (HPV) is detected in up to 96% of anal squamous cell cancers, where
screening programs needed. However, the best methodology is still undetermined. Host …

Background Anal cancer prevention has two critical points: the incidence rate is several fold
higher for some groups, such as people living with human immunodeficiency virus (HIV) and …

HIV infection is one of the strongest risk factors for anal squamous cell cancer (ASCC). Most
ASCC are caused by HPV, and most HPV-associated ASCC are caused by HPV-16. Anal …

Abstract Background. Carcinogenic human papillomaviruses (HPVs) cause a large
proportion of anal cancers. Human immunodeficiency virus (HIV)–infected men who have …

Background Human papillomavirus (HPV)-related biomarkers have shown good cross-
sectional performance for anal precancer detection in human immunodeficiency virus …